Meanwhile, USP36 expression was negatively associated with the sensitivity of cancer cells to the anti-cancer drug olaparib, as evidenced by analysis of the data from the CellMinerCDB (37) in 43 ovarian cancer cell lines (Figure 7F). Here, USP36 is linked to ovarian cancer.